News
PKTX
0.0002
NaN%
--
Weekly Report: what happened at PKTX last week (0824-0828)?
Weekly Report · 5d ago
Weekly Report: what happened at PKTX last week (0817-0821)?
Weekly Report · 08/24 09:16
Weekly Report: what happened at PKTX last week (0810-0814)?
Weekly Report · 08/17 09:16
ProtoKinetix delays quarterly SEC filing
TipRanks · 08/14 22:26
Weekly Report: what happened at PKTX last week (0803-0807)?
Weekly Report · 08/10 09:15
Weekly Report: what happened at PKTX last week (0727-0731)?
Weekly Report · 08/03 09:15
Weekly Report: what happened at PKTX last week (0720-0724)?
Weekly Report · 07/27 09:16
Weekly Report: what happened at PKTX last week (0713-0717)?
Weekly Report · 07/20 09:16
Weekly Report: what happened at PKTX last week (0706-0710)?
Weekly Report · 07/13 09:16
Weekly Report: what happened at PKTX last week (0629-0703)?
Weekly Report · 07/06 09:17
Weekly Report: what happened at PKTX last week (0622-0626)?
Weekly Report · 06/29 09:16
Weekly Report: what happened at PKTX last week (0615-0619)?
Weekly Report · 06/22 09:18
ProtoKinetix Revamps Board With New Directors and President
TipRanks · 06/17 22:59
Weekly Report: what happened at PKTX last week (0608-0612)?
Weekly Report · 06/15 09:17
Weekly Report: what happened at PKTX last week (0601-0605)?
Weekly Report · 06/08 09:17
Weekly Report: what happened at PKTX last week (0525-0529)?
Weekly Report · 06/01 09:18
Weekly Report: what happened at PKTX last week (0518-0522)?
Weekly Report · 05/25 09:18
Weekly Report: what happened at PKTX last week (0511-0515)?
Weekly Report · 05/18 09:18
ProtoKinetix Flags Delay in Quarterly Filing
TipRanks · 05/15 18:18
Weekly Report: what happened at PKTX last week (0504-0508)?
Weekly Report · 05/11 09:18
More
Webull provides a variety of real-time PKTX stock news. You can receive the latest news about Protokinetix Inc through multiple platforms. This information may help you make smarter investment decisions.
About PKTX
ProtoKinetix, Incorporated is a research and development stage biotechnology company. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company's anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The Company has not developed a commercially viable product and has not generated any revenue.